Views & Analysis 5 years of biosimilars in the US: what have we learned? Biologics have created revolutionary treatment options that have transformed the care journey for hundreds of millions of patients worldwide.
Views & Analysis Making real world evidence fit for purpose Although real world evidence (RWE) is a hot topic in pharma right now, many still question whether it is acceptable to be used in regulatory decision making.
Views & Analysis Future prospects for an Innovative Medicines Fund for Englan... On the 12 December 2019, the UK general public voted for a further five years of Conservative government.
Views & Analysis Nine pharma trends for 2020 Sarah Rickwood looks back at how pharma changed over the last decade and what this might mean for the industry in 2020.
Views & Analysis The 4 biggest pharma market access stories of 2019 What events have defined the market access landscape in 2019, and what trends will shape 2020? We dive into the pharmaphorum archives to find out.
Views & Analysis An alternative set of metrics for the UK’s pricing and acces... Leela Barham takes a look at alternative ways pharma and the UK government could measure progress for the VPAS.
News AI giant Anthropic buys Coefficient Bio for $400m Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.